Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

TASMAN PHARMA

  • FDA Approval
  • April 27, 2023, 11:47 UTC
  • 37
  • 0 comments

FDA approve CLOZAPINE

Comment Full text

DR REDDYS LABS LTD

  • FDA Approval
  • April 27, 2023, 11:47 UTC
  • 35
  • 0 comments

FDA approve ATORVASTATIN CALCIUM

Comment Full text

ACTAVIS LABS FL INC

  • FDA Approval
  • April 27, 2023, 11:47 UTC
  • 38
  • 0 comments

FDA approve RAMELTEON

Comment Full text

DR REDDYS LABS LTD

  • FDA Approval
  • April 27, 2023, 11:47 UTC
  • 37
  • 0 comments

FDA approve ATORVASTATIN CALCIUM

Comment Full text

APPCO

  • FDA Approval
  • April 27, 2023, 11:47 UTC
  • 37
  • 0 comments

FDA approve METAXALONE

Comment Full text

GLAXOSMITHKLINE

  • FDA Approval
  • April 27, 2023, 11:47 UTC
  • 38
  • 0 comments

FDA approve NIRAPARIB TOSYLATE

Comment Full text

LIEBEL-FLARSHEIM

  • FDA Approval
  • April 27, 2023, 11:47 UTC
  • 32
  • 0 comments

FDA approve IOTHALAMATE MEGLUMINE

Comment Full text

VERTEX PHARMS INC

  • FDA Approval
  • April 27, 2023, 11:47 UTC
  • 33
  • 0 comments

FDA approve ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • April 27, 2023, 11:47 UTC
  • 34
  • 0 comments

FDA approve SPIRONOLACTONE

Comment Full text

PADAGIS ISRAEL

  • FDA Approval
  • April 27, 2023, 11:47 UTC
  • 36
  • 0 comments

FDA approve TAZAROTENE

Comment Full text
  • Previous
  • 830
  • 831
  • 832
  • 833
  • 834
  • Next

Search

News categories

  • Technical Exchange News(14775)
  • Event(6229)
  • SEC News(398991)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(243084)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin